Membrane-coated nanoparticles as a biomimetic targeted delivery system for tumour therapy

• Published in: Biomaterials translational 2024, Vol.5 (1), p.33
• Main Authors: Guo, Haoyu, Guo, Mingke, Xia, Zhidao, Shao, Zengwu
• Format: Article
• Language: English
• ISSN: 2096-112X; 2096-112X
• DOI: 10.12336/biomatertransl.2024.01.004

Drug therapy towards tumours often causes adverse effects because of their non-specific nature. Membrane-coated technology and membrane-coated nanoparticles provide an advanced and promising platform of targeted and safe delivery. By camouflaging the nanoparticles with natural derived or artificially modified cell membranes, the nano-payloads are bestowed with properties from cell membranes such as longer circulation, tumour or inflammation-targeting, immune stimulation, augmenting the performance of traditional therapeutics. In this review, we review the development of membrane coating technology, and summarise the technical details, physicochemical properties, and research status of membrane-coated nanoparticles from different sources in tumour treatment. Finally, we also look forward to the prospects and challenges of transforming membrane coating technology from experiment into clinical use. Taken together, membrane-coated nanoparticles are bound to become one of the most potential anti-tumour strategies in the future.